After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NYSE listed company, DGX falls under the Healthcare sector while operating within the Diagnostics & Research industry segment. The current market capitalization of Quest Diagnostics, Inc is $18.32B. A total of 2.7 million shares were traded on the day, compared to an average of 737.69K shares.
In the most recent transaction, DEPPE MICHAEL J sold 18,755 shares of DGX for 154.05 per share on Nov 06 ’24. After the transaction, the SVP, Corp. Controller & CAO now owns 34,941 company shares. In a previous transaction on Oct 28 ’24, KUPPUSAMY KARTHIK sold 1,775 shares at 156.92 per share. DGX shares that SVP, Clinical Solutions owns now total 9,734.
Among the insiders who bought shares, KUPPUSAMY KARTHIK acquired of 1,775 shares on Oct 28 ’24 at a per-share price of $156.87. In another insider transaction, PREVOZNIK MICHAEL E sold 32,551 shares at $154.97 per share on Aug 29 ’24. Company shares held by the SVP & General Counsel now total 38,478.
Dividend
Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. Quest Diagnostics, Inc pays an annual dividend of $2.96, resulting in a dividend yield of 1.84%, and it has a price to earnings (P/E) ratio of 21.54. DGX’s most recent ex-dividend date was 1/14/2025 when it declared a $0.75 quarterly dividend that was paid in cash on 1/29/2025. Previously, the company paid the dividend on 10/21/2024 with an ex-dividend date of 10/4/2024. The DGX stock dividend was $0.75 per share in cash.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, DGX has a high of $162.59 and a low of $123.04.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. DGX’s latest balance sheet shows that the firm has $872.00M in Cash & Short Term Investments as of fiscal 2021. There were $4.77B in debt and $1.75B in liabilities at the time. Its Book Value Per Share was $60.79, while its Total Shareholder’s Equity was $6.56B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DGX is Buy with a score of 3.88.
